Aegerion Pharmaceuticals to Announce Second Quarter 2012 Financial Results on Wednesday, August 8
CAMBRIDGE, Mass., July 20, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare disorders, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. ET on Wednesday, August 8, 2012, to provide a business update and discuss its second quarter 2012 financial and operational results.
To listen to the live webcast of the call, please visit the "Investors" section of the Company's website at www.aegerion.com. Individuals may also participate in the call via telephone by dialing (866) 516-3002 or (760) 298-5082. Interested parties unable to join the live call may access an archived version of the webcast on Aegerion's website following the call.
Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) is committed to changing the way rare, life-threatening disorders are treated. We are an emerging biopharmaceutical company focused on the development and commercialization of novel, life-altering therapeutics to treat debilitating and often fatal rare diseases. Aegerion is motivated by its commitment to patients first. We are also attentive to our core values of integrity, innovation, responsibility to healthcare providers, development of employees and always scientific and clinical excellence.
CONTACT: Aegerion Pharmaceuticals, Inc. Michael Lawless, VP, IR 857-242-5028 LaVoie Group Amanda Murphy 978-745-4200 X103Source: Aegerion Pharmaceuticals, Inc. 2012 GlobeNewswire, Inc.